Doctors in England launch trial of blood tests to spot cancer earlier
Doctors in England launch trial of blood tests to spot cancer earlier
Doctors in England launch trial of blood tests to spot cancer earlier
Key points
اہم نکات
मुख्य बातें
- England has launched a world-first trial to test whether simple blood tests can help family doctors spot cancer earlier.
- More than 20,000 NHS patients aged 45 and over who visit their GP with abdominal symptoms such as persistent bloating will take part across at least 200 practices.
- The tests, part of the STRIDE-RCT trial led by the University of Birmingham, look for signs of 13 cancers — including bowel, pancreatic, ovarian, liver and prostate cancer — in a single blood sample, using artificial intelligence and protein measurements.
- England has launched a world-first trial to test whether simple blood tests can help family doctors spot cancer earlier.
- More than 20,000 NHS patients aged 45 and over who visit their GP with abdominal symptoms such as persistent bloating will take part across at least 200 practices.
- The tests, part of the STRIDE-RCT trial led by the University of Birmingham, look for signs of 13 cancers — including bowel, pancreatic, ovarian, liver and prostate cancer — in a single blood sample, using artificial intelligence and protein measurements.
- England has launched a world-first trial to test whether simple blood tests can help family doctors spot cancer earlier.
- More than 20,000 NHS patients aged 45 and over who visit their GP with abdominal symptoms such as persistent bloating will take part across at least 200 practices.
- The tests, part of the STRIDE-RCT trial led by the University of Birmingham, look for signs of 13 cancers — including bowel, pancreatic, ovarian, liver and prostate cancer — in a single blood sample, using artificial intelligence and protein measurements.
England has launched a world-first trial to test whether simple blood tests can help family doctors spot cancer earlier. More than 20,000 NHS patients aged 45 and over who visit their GP with abdominal symptoms such as persistent bloating will take part across at least 200 practices. The tests, part of the STRIDE-RCT trial led by the University of Birmingham, look for signs of 13 cancers — including bowel, pancreatic, ovarian, liver and prostate cancer — in a single blood sample, using artificial intelligence and protein measurements. A positive result is not a diagnosis, but it could help doctors decide who needs an urgent referral. The trial has up to £8.49 million in government funding, and any wider NHS use will depend on the results.
England has launched a world-first trial to test whether simple blood tests can help family doctors spot cancer earlier. More than 20,000 NHS patients aged 45 and over who visit their GP with abdominal symptoms such as persistent bloating will take part across at least 200 practices. The tests, part of the STRIDE-RCT trial led by the University of Birmingham, look for signs of 13 cancers — including bowel, pancreatic, ovarian, liver and prostate cancer — in a single blood sample, using artificial intelligence and protein measurements. A positive result is not a diagnosis, but it could help doctors decide who needs an urgent referral. The trial has up to £8.49 million in government funding, and any wider NHS use will depend on the results.
England has launched a world-first trial to test whether simple blood tests can help family doctors spot cancer earlier. More than 20,000 NHS patients aged 45 and over who visit their GP with abdominal symptoms such as persistent bloating will take part across at least 200 practices. The tests, part of the STRIDE-RCT trial led by the University of Birmingham, look for signs of 13 cancers — including bowel, pancreatic, ovarian, liver and prostate cancer — in a single blood sample, using artificial intelligence and protein measurements. A positive result is not a diagnosis, but it could help doctors decide who needs an urgent referral. The trial has up to £8.49 million in government funding, and any wider NHS use will depend on the results.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।